Trospium Chloride Tablet, Film Coated
Product Images NDC 63629-9279

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 63629-9279). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure diagram of Trospium Chloride, depicting the molecular arrangement of atoms and bonds characteristic of this active pharmaceutical ingredient.*

FDA Label Image

Figure 1 (Image 02)

A line graph displaying plasma concentration (ng/mL) over time (hours post-dose) with data points and error bars indicating variability. The concentration peaks shortly after dose administration and gradually declines over 48 hours.*

FDA Label Image

Figure 2 (Image 03)

A line graph depicting mean change (± SE) over 12 weeks of treatment comparing Trospium Chloride tablets (solid line with solid circles, N=253) versus placebo (dotted line with open circles, N=256). The x-axis represents weeks of treatment (1, 4, 12), and the y-axis represents mean change with decreasing values. Trospium Chloride group shows a greater mean decrease over time with p-values indicating statistical significance at weeks 4 and 12.*

FDA Label Image

Figure 3 (Image 04)

A line graph comparing mean change with standard error (SE) between placebo and Trospium Chloride tablets over 12 weeks of treatment. The x-axis shows weeks of treatment (1, 4, 12), and the y-axis shows mean change values. Data points are plotted for both groups, with placebo indicated by dashed lines and Trospium Chloride by solid lines, including p-values for statistical analysis at weeks 1, 4, and 12.*

FDA Label Image

Figure 4 (Image 05)

A line graph comparing mean change over weeks of treatment between Trospium Chloride tablets and placebo groups. The x-axis shows week 1, 4, and 12 of treatment, while the y-axis indicates mean change values. Trospium Chloride group shows a greater decrease compared to placebo, with statistical significance noted.*

FDA Label Image

Figure 5 (Image 06)

A line graph comparing mean change over weeks of treatment between placebo and Trospium Chloride tablets. The x-axis represents weeks 1, 4, and 12 of treatment, and the y-axis shows mean change with standard error. Trospium Chloride tablets show a greater mean reduction than placebo at all time points with indicated statistical significance (p<0.001).*

FDA Label Image

Label (Lbl636299279)

Label for Trospium Chloride tablets, 20 mg strength, oral film-coated tablets. The label shows the product name and strength prominently, NDC 63629-9279-1, and states the quantity as 60 tablets. The labeler is Bryant Ranch Prepack. Barcode and storage instructions are also present on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.